Jared Kaltwasser

Patients with relapsing/remitting chronic lymphocytic leukemia (CLL) have a range of new therapeutic options. A new study is the first to directly compare 2 of the more prominent new therapies.

A new review article shows scientific studies have consistently identified links between sleep problems and health outcomes in patients with type 1 diabetes (T1D). Despite the apparent links, there are no screening recommendations related to sleep in patients with the disease.

A new study suggests patients whose systolic blood pressure varies significantly over time might be at greater risk of higher multiple sclerosis disability.

Drug developers have made significant strides in understanding narcolepsy in recent years. Now, those advances are translating into a robust pipeline of potential new therapies.

In a major study of a Chinese medical insurance database, investigators found the prevalence and incidence of the disease in China is similar to those of its neighbors, but lower than countries in the West.

Though rare, patients with both autoimmune hemolytic anemia (AHIA) and non-Hodgkin lymphoma face stark odds of long-term survival. A new study lends insights into how to best diagnose and treat those patients.

It can be difficult to notice when a patient is transitioning from relapsing-remitting multiple sclerosis to the secondary progressive form. Soon, neurologists may be able to use a digital tool to catch it.

There’s significant evidence that some patients with far-advanced glaucoma are able to perform more tasks than others. Yet, it’s difficult to distinguish these patients from each other. A new study proposes a way to find out.

There’s not much research available comparing the Paleolithic diet to other popular nutritional plans. A new study sought to scour existing data to see the Paleolithic diet’s effect on glucose and insulin regulation. The data showed no significant impact.

Patients undergoing immunotherapy could be at risk for psoriasis flare-ups, even if the patient is asymptomatic at the initiation of cancer treatment. A newly published case report outlines a rare case where immunotherapy had to be stopped due to severe skin lesions.

Primary and acquired resistance to bortezomib can increase recurrence rates in patients with multiple myeloma. A new strategy could help reduce resistance.

New research confirms that end-stage renal disease is a significant risk factor for patients undergoing cataract surgery.

A British study shows nonmedical costs make up a significant portion of the annual expense generated by multiple sclerosis (MS). Most of those nonmedical costs are not covered by insurance.

Scientists have long known that both microglia and blood-derived macrophages play roles in how the central nervous system responds to demyelination, which occurs in multiple sclerosis. A new study explains how the two interact.

New research finds salivary antioxidants and oxidative stress could be important biomarkers for plaque psoriasis.

Scientists say they know which isoform of a key protein is most likely to lead to a rare type of muscular dystrophy.

A new review article says neuroinflammation and oxidative stress appear to act together to weaken the diabetic retina and optic nerve; the authors say these insights could someday lead to better therapies to prevent diabetic retinopathy.

New targeted therapies like ibrutinib, idelalisib, and venetoclax appear to be highly successful in the treatment of chronic lymphocytic leukemia (CLL), but investigators say it’s unclear how those therapies impact autoimmune complications of the cancer.